• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞胆固醇流出与接受冠状动脉造影术患者的脂蛋白亚类分布及阻塞性冠状动脉疾病风险相关。

Macrophage cholesterol efflux correlates with lipoprotein subclass distribution and risk of obstructive coronary artery disease in patients undergoing coronary angiography.

作者信息

Linsel-Nitschke Patrick, Jansen Henning, Aherrarhou Zouhair, Belz Stefanie, Mayer Björn, Lieb Wolfgang, Huber Fritz, Kremer Werner, Kalbitzer Hans-Robert, Erdmann Jeanette, Schunkert Heribert

机构信息

Department of Medicine, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.

出版信息

Lipids Health Dis. 2009 Apr 6;8:14. doi: 10.1186/1476-511X-8-14.

DOI:10.1186/1476-511X-8-14
PMID:19348677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2674428/
Abstract

BACKGROUND

Studies in patients with low HDL have suggested that impaired cellular cholesterol efflux is a heritable phenotype increasing atherosclerosis risk. Less is known about the association of macrophage cholesterol efflux with lipid profiles and CAD risk in normolipidemic subjects. We have therefore measured macrophage cholesterol efflux in 142 normolipidemic subjects undergoing coronary angiography.

METHODS

Monocytes isolated from blood samples of patients scheduled for cardiac catheterization were differentiated into macrophages over seven days. Isotopic cholesterol efflux to exogenously added apolipoprotein A-I and HDL2 was measured. Quantitative cholesterol efflux from macrophages was correlated with lipoprotein subclass distribution in plasma from the same individuals measured by NMR-spectroscopy of lipids and with the extent of coronary artery disease seen on coronary angiography.

RESULTS

Macrophage cholesterol efflux was positively correlated with particle concentration of smaller HDL and LDL particles but not with total plasma concentrations of HDL or LDL-cholesterol. We observed an inverse relationship between macrophage cholesterol efflux and the concentration of larger and triglyceride rich particles (VLDL, chylomicrons). Subjects with significant stenosis on coronary angiography had lower cholesterol efflux from macrophages compared to individuals without significant stenosis (adjusted p = 0.02).

CONCLUSION

Macrophage cholesterol efflux is inversely correlated with lipoprotein particle size and risk of CAD.

摘要

背景

对高密度脂蛋白(HDL)水平较低患者的研究表明,细胞胆固醇流出受损是一种可遗传的表型,会增加动脉粥样硬化风险。在血脂正常的受试者中,巨噬细胞胆固醇流出与血脂谱及冠心病风险之间的关联鲜为人知。因此,我们对142名接受冠状动脉造影的血脂正常受试者的巨噬细胞胆固醇流出情况进行了测量。

方法

从计划进行心脏导管插入术患者的血样中分离出单核细胞,在7天内将其分化为巨噬细胞。测量向外源性添加的载脂蛋白A-I和HDL2的同位素胆固醇流出。巨噬细胞的定量胆固醇流出与通过脂质核磁共振光谱法测量的同一受试者血浆中的脂蛋白亚类分布以及冠状动脉造影所见的冠状动脉疾病程度相关。

结果

巨噬细胞胆固醇流出与较小HDL和LDL颗粒的颗粒浓度呈正相关,但与HDL或LDL胆固醇的总血浆浓度无关。我们观察到巨噬细胞胆固醇流出与较大且富含甘油三酯的颗粒(极低密度脂蛋白、乳糜微粒)浓度之间呈负相关。与无明显狭窄的个体相比,冠状动脉造影有明显狭窄的受试者巨噬细胞的胆固醇流出较低(校正p = 0.02)。

结论

巨噬细胞胆固醇流出与脂蛋白颗粒大小及冠心病风险呈负相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a6/2674428/fb4a0cbe2d8c/1476-511X-8-14-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a6/2674428/fc25a22f90fe/1476-511X-8-14-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a6/2674428/540ac5ad76d2/1476-511X-8-14-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a6/2674428/fb4a0cbe2d8c/1476-511X-8-14-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a6/2674428/fc25a22f90fe/1476-511X-8-14-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a6/2674428/540ac5ad76d2/1476-511X-8-14-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a6/2674428/fb4a0cbe2d8c/1476-511X-8-14-3.jpg

相似文献

1
Macrophage cholesterol efflux correlates with lipoprotein subclass distribution and risk of obstructive coronary artery disease in patients undergoing coronary angiography.巨噬细胞胆固醇流出与接受冠状动脉造影术患者的脂蛋白亚类分布及阻塞性冠状动脉疾病风险相关。
Lipids Health Dis. 2009 Apr 6;8:14. doi: 10.1186/1476-511X-8-14.
2
High-Density Lipoprotein Particles, Cell-Cholesterol Efflux, and Coronary Heart Disease Risk.高密度脂蛋白颗粒、细胞胆固醇外流与冠心病风险
Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2007-2015. doi: 10.1161/ATVBAHA.118.311117.
3
High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.高密度脂蛋白胆固醇流出能力作为动脉粥样硬化性冠心病的相关预测指标。
Atherosclerosis. 2015 Sep;242(1):318-22. doi: 10.1016/j.atherosclerosis.2015.06.028. Epub 2015 Jul 13.
4
Persistent changes in lipoprotein lipids after a single infusion of ascending doses of MDCO-216 (apoA-IMilano/POPC) in healthy volunteers and stable coronary artery disease patients.在健康志愿者和稳定型冠状动脉疾病患者中单次输注递增剂量的MDCO-216(载脂蛋白A-米兰/1-棕榈酰-2-油酰磷脂酰胆碱)后脂蛋白脂质的持续变化。
Atherosclerosis. 2016 Dec;255:17-24. doi: 10.1016/j.atherosclerosis.2016.10.042. Epub 2016 Oct 24.
5
High-Density Lipoprotein Particle Concentration and Size Predict Incident Coronary Artery Disease Events in a Cohort With Type 1 Diabetes.高密度脂蛋白颗粒浓度和大小可预测 1 型糖尿病患者发生冠心病事件的风险。
J Am Heart Assoc. 2024 Jul 16;13(14):e034763. doi: 10.1161/JAHA.123.034763. Epub 2024 Jul 3.
6
Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.胆固醇流出能力百分比和总胆固醇流出能力在有或无冠状动脉疾病患者中的意义。
Heart Vessels. 2017 Jan;32(1):30-38. doi: 10.1007/s00380-016-0837-7. Epub 2016 Apr 22.
7
Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.阿托伐他汀在IIB型高脂血症中的剂量依赖性作用:优先且逐步降低致动脉粥样硬化的含载脂蛋白B的脂蛋白亚类(VLDL-2、IDL、小而密LDL)并刺激细胞胆固醇外流。
Atherosclerosis. 2002 Aug;163(2):287-96. doi: 10.1016/s0021-9150(02)00037-0.
8
Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.胆固醇外排增加与心血管事件风险增加呈矛盾关联。
Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1696-705. doi: 10.1161/ATVBAHA.113.301373. Epub 2013 Mar 21.
9
Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.稳定型冠状动脉疾病患者血浆磷脂酶A2浓度与脂蛋白亚组分之间的关系。
Clin Chim Acta. 2015 Jun 15;446:195-200. doi: 10.1016/j.cca.2015.04.032. Epub 2015 Apr 28.
10
HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.高密度脂蛋白颗粒大小是 ABCA1 介导的巨噬细胞细胞胆固醇流出的关键决定因素。
Circ Res. 2015 Mar 27;116(7):1133-42. doi: 10.1161/CIRCRESAHA.116.305485. Epub 2015 Jan 14.

引用本文的文献

1
Hypertriglyceridemia and Atherosclerotic Carotid Artery Stenosis.高甘油三酯血症与动脉粥样硬化性颈动脉狭窄。
Int J Mol Sci. 2022 Dec 19;23(24):16224. doi: 10.3390/ijms232416224.
2
High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacity Are Not Affected by Supervised Exercise but Are Associated with Baseline Interleukin-6 in Patients with Peripheral Artery Disease.高密度脂蛋白亚组分与胆固醇流出能力不受监督运动的影响,但与外周动脉疾病患者的基线白细胞介素-6相关。
Front Cardiovasc Med. 2017 Mar 2;4:9. doi: 10.3389/fcvm.2017.00009. eCollection 2017.
3
Cholesterol Efflux Capacity of Apolipoprotein A-I Varies with the Extent of Differentiation and Foam Cell Formation of THP-1 Cells.

本文引用的文献

1
Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity.血清,而非来自低高密度脂蛋白胆固醇(HDL-C)受试者的单核细胞巨噬细胞泡沫细胞,表现出降低的胆固醇流出能力。
J Lipid Res. 2009 Feb;50(2):183-92. doi: 10.1194/jlr.M800196-JLR200. Epub 2008 Sep 11.
2
The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential.LXR激动剂T0901317通过增加血浆流出潜力促进巨噬细胞的胆固醇逆向转运。
J Lipid Res. 2008 May;49(5):954-60. doi: 10.1194/jlr.M700254-JLR200. Epub 2008 Feb 5.
3
Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL.
载脂蛋白A-I的胆固醇流出能力随THP-1细胞的分化程度和泡沫细胞形成而变化。
J Lipids. 2016;2016:9891316. doi: 10.1155/2016/9891316. Epub 2016 Nov 9.
4
Familial hypercholesterolaemia: cholesterol efflux and coronary disease.家族性高胆固醇血症:胆固醇流出与冠状动脉疾病
Eur J Clin Invest. 2016 Jul;46(7):643-50. doi: 10.1111/eci.12643. Epub 2016 Jun 20.
5
Serum microRNA-1233 is a specific biomarker for diagnosing acute pulmonary embolism.血清微小RNA-1233是诊断急性肺栓塞的一种特异性生物标志物。
J Transl Med. 2016 May 5;14(1):120. doi: 10.1186/s12967-016-0886-9.
6
The effects of apolipoprotein B depletion on HDL subspecies composition and function.载脂蛋白B缺乏对高密度脂蛋白亚类组成和功能的影响。
J Lipid Res. 2016 Apr;57(4):674-86. doi: 10.1194/jlr.M066613. Epub 2016 Feb 23.
7
Nitrated apolipoprotein AI/apolipoprotein AI ratio is increased in diabetic patients with coronary artery disease.糖尿病合并冠心病患者的硝化载脂蛋白AI/载脂蛋白AI比值升高。
Atherosclerosis. 2016 Feb;245:12-21. doi: 10.1016/j.atherosclerosis.2015.11.021. Epub 2015 Nov 24.
8
High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity.人体研究中的高密度脂蛋白功能测量:聚焦胆固醇流出能力。
Prog Cardiovasc Dis. 2015 Jul-Aug;58(1):32-40. doi: 10.1016/j.pcad.2015.05.004. Epub 2015 May 9.
9
High-density lipoprotein particle concentration and subclinical atherosclerosis of the carotid arteries in Japanese men.日本男性高密度脂蛋白颗粒浓度与颈动脉亚临床动脉粥样硬化
Atherosclerosis. 2015 Apr;239(2):444-50. doi: 10.1016/j.atherosclerosis.2015.01.031. Epub 2015 Jan 31.
10
Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective.CETP 抑制剂的未来:药理学视角。
Clin Pharmacokinet. 2013 Aug;52(8):615-26. doi: 10.1007/s40262-013-0071-8.
家族性低高密度脂蛋白受试者中常见的ABCA1变异、高密度脂蛋白水平与细胞胆固醇流出
J Lipid Res. 2007 Jun;48(6):1409-16. doi: 10.1194/jlr.P600012-JLR200. Epub 2007 Mar 19.
4
Genetic etiology of isolated low HDL syndrome: incidence and heterogeneity of efflux defects.孤立性低高密度脂蛋白综合征的遗传病因:胆固醇流出缺陷的发生率及异质性
Arterioscler Thromb Vasc Biol. 2007 May;27(5):1139-45. doi: 10.1161/ATVBAHA.106.137646. Epub 2007 Feb 15.
5
Knockdown of hepatic ABCA1 by RNA interference decreases plasma HDL cholesterol levels and influences postprandial lipemia in mice.通过RNA干扰敲低肝脏ABCA1可降低小鼠血浆高密度脂蛋白胆固醇水平并影响餐后血脂异常。
Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1433-8. doi: 10.1161/01.ATV.0000166616.86723.d0. Epub 2005 Apr 21.
6
Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.肝脏中Abca1的靶向失活会导致严重的低α脂蛋白血症和载脂蛋白A-I的肾脏高分解代谢。
J Clin Invest. 2005 May;115(5):1333-42. doi: 10.1172/JCI23915. Epub 2005 Apr 7.
7
HDL as a target in the treatment of atherosclerotic cardiovascular disease.高密度脂蛋白作为动脉粥样硬化性心血管疾病治疗的靶点。
Nat Rev Drug Discov. 2005 Mar;4(3):193-205. doi: 10.1038/nrd1658.
8
A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR.核胆汁酸受体FXR的化学、遗传及结构分析
Mol Cell. 2003 Apr;11(4):1079-92. doi: 10.1016/s1097-2765(03)00104-7.
9
The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia.ABCA1转运蛋白的作用及胆固醇流出在家族性低α脂蛋白血症中的作用
J Lipid Res. 2003 Jun;44(6):1251-5. doi: 10.1194/jlr.M300080-JLR200. Epub 2003 Apr 16.
10
Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency.高密度脂蛋白缺乏时的细胞磷脂和胆固醇流出
Circulation. 2003 Mar 18;107(10):1366-71. doi: 10.1161/01.cir.0000056764.53152.f9.